Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
HES
Hess
HES
|
+$1.28B |
| 2 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$1.02B |
| 3 |
Bank of America
BAC
|
+$770M |
| 4 |
Gilead Sciences
GILD
|
+$378M |
| 5 |
Chipotle Mexican Grill
CMG
|
+$346M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.78B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$973M |
| 3 |
Walt Disney
DIS
|
+$588M |
| 4 |
Eli Lilly
LLY
|
+$569M |
| 5 |
AT&T
T
|
+$529M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 3.4% |
| 2 | Healthcare | 3.08% |
| 3 | Financials | 2.41% |
| 4 | Consumer Discretionary | 2.33% |
| 5 | Industrials | 1.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
8826
Hartford US Quality Growth ETF
HQGO
$50.7M
| $391K | ﹤0.01% |
8,300
-1,526
| -16% | -$68.4K |
|
|
IMOS
8827
ChipMOS TECHNOLOGIES
IMOS
$1.99B
| $390K | ﹤0.01% |
12,416
+3,891
| +46% | +$111K |
|
8828
GraniteShares 2x Long COIN Daily ETF
CONL
$418M
| $390K | ﹤0.01% |
5,088
+896
| +21% | +$36.6K |
|
8829
PUT
Kymera Therapeutics
KYMR
$10.1B
| $390K | ﹤0.01% |
9,700
+1,600
| +20% | +$57.2K |
|
8830
CALL
Denali Therapeutics
DNLI
$3.89B
| $390K | ﹤0.01% |
19,000
+12,400
| +188% | +$233K |
|
8831
Bankwell Financial Group
BWFG
$539M
| $390K | ﹤0.01% |
15,023
-875
| -6% | -$23.3K |
|
8832
CALL
Direxion Daily MSCI India Bull 2X ETF
INDL
$56.4M
| $390K | ﹤0.01% |
6,300
-1,300
| -17% | -$77.9K |
|
8833
AdvisorShares Insider Advantage ETF
SURE
$57.7M
| $389K | ﹤0.01% |
3,331
+994
| +43% | +$108K |
|
|
INST
8834
PUT
DELISTED
Instructure Holdings, Inc.
INST
| $389K | ﹤0.01% |
18,200
+17,400
| +2,175% | +$410K |
|
8835
Taylor Devices
TAYD
$178M
| $389K | ﹤0.01% |
+7,816
| New | +$273K |
|
8836
Fidelity Disruptive Automation ETF
FBOT
$224M
| $389K | ﹤0.01% |
14,594
-8,874
| -38% | -$225K |
|
8837
MediWound
MDWD
$172M
| $387K | ﹤0.01% |
27,187
+10,489
| +63% | +$144K |
|
8838
CALL
MBIA
MBI
$252M
| $387K | ﹤0.01% |
57,300
-36,400
| -39% | -$230K |
|
8839
CALL
Eastern Bankshares
EBC
$5.4B
| $387K | ﹤0.01% |
28,100
+4,300
| +18% | +$58.4K |
|
8840
PUT
ESAB
ESAB
$5.11B
| $387K | ﹤0.01% |
3,500
+1,878
| +116% | +$175K |
|
8841
PUT
Essent Group
ESNT
$6.24B
| $387K | ﹤0.01% |
6,500
+5,700
| +713% | +$310K |
|
8842
CALL
Northwest Bancshares
NWBI
$2.3B
| $387K | ﹤0.01% |
33,200
+27,300
| +463% | +$324K |
|
8843
CALL
Titan International
TWI
$427M
| $386K | ﹤0.01% |
31,000
-7,700
| -20% | -$106K |
|
8844
OmniAb
OABI
$555M
| $386K | ﹤0.01% |
71,182
+57,273
| +412% | +$330K |
|
8845
ALPS Active Equity Opportunity ETF
RFFC
$32.8M
| $386K | ﹤0.01% |
+7,295
| New | +$364K |
|
8846
CALL
Schwab US REIT ETF
SCHH
$11.3B
| $386K | ﹤0.01% |
19,000
-1,800
| -9% | -$36.1K |
|
|
ADAP
8847
DELISTED
Adaptimmune Therapeutics
ADAP
| $385K | ﹤0.01% |
243,691
-3,155,823
| -93% | -$3.81M |
|
|
TELL
8848
PUT
DELISTED
Tellurian Inc.
TELL
| $385K | ﹤0.01% |
582,000
-363,000
| -38% | -$246K |
|
|
GTHX
8849
CALL
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
| $385K | ﹤0.01% |
89,100
+39,000
| +78% | +$136K |
|
8850
PUT
Bally's
BALY
$505M
| $385K | ﹤0.01% |
27,600
+12,900
| +88% | +$150K |
|
Similar funds
Citadel Advisors's Q1 2024 Portfolio in Review
As of Q1 2024, Citadel Advisors held 15,912 positions worth $518B, up 3.6% from $500B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Citadel Advisors withdrew a net $36B in Q1 2024, closing 1,439 positions and reducing 6,148 holdings. Its most notable exit was iShares National Muni Bond ETF, an estimated $183M position sold in full.
By sector, the portfolio is most concentrated in Technology at 3.4% of assets, down from 3.8% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Citadel Advisors opened a new position in TD Synnex worth $245M.
- Citadel Advisors's largest Q1 2024 buy was TD Synnex: 2,162,840 shares worth $245M.
- Citadel Advisors added most to Hess in Q1 2024, an estimated $1.28B increase.
- Citadel Advisors's biggest Q1 2024 reduction was NVIDIA, cutting an estimated $1.78B.
- Citadel Advisors fully exited iShares National Muni Bond ETF in Q1 2024, selling an estimated $183M.
- Citadel Advisors's ten largest holdings make up 30% of its $518B portfolio in Q1 2024.
- Citadel Advisors opened 1,748 new positions and closed 1,439 in Q1 2024.
- Citadel Advisors's portfolio value rose 3.6% quarter-over-quarter to $518B.
Based on Citadel Advisors's 13F filing for Q1 2024, filed 15 May 2024.